ORBIMED ADVISORS LLC 13D and 13G filings for VectivBio Holding AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-24 4:52 pm Sale |
2023-05-21 | 13D | VectivBio Holding AG VECT |
ORBIMED ADVISORS LLC | 5,156,561 7.700% |
-1,557,000 (-23.19%) |
Filing |
| 2023-02-14 5:12 pm Purchase |
2022-12-31 | 13G | VectivBio Holding AG VECT |
ORBIMED ADVISORS LLC | 6,713,561 10.700% |
1,810,057 (+36.91%) |
Filing |
| 2022-02-11 4:51 pm Purchase |
2021-12-31 | 13G | VectivBio Holding AG VECT |
ORBIMED ADVISORS LLC | 4,903,504 14.000% |
73,500 (+1.52%) |
Filing |
| 2021-04-20 4:37 pm Purchase |
2021-04-13 | 13G | VectivBio Holding AG VECT |
ORBIMED ADVISORS LLC | 4,830,004 13.800% |
4,830,004 (New Position) |
Filing |